Organon Llc Drug Patent Portfolio

Organon Llc owns 8 orange book drugs protected by 54 US patents with Xaciato having the least patent protection, holding only 1 patent. And Asmanex Twisthaler with maximum patent protection, holding 21 patents. Given below is the list of Organon Llc's drug patents along with their expiration dates.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US11129896 Topical formulations and treatments 22 Sep, 2036
Active
US7618649 Extended release oral dosage composition 19 Jun, 2021 Expired
US6709676 Extended release oral dosage composition 18 Feb, 2021 Expired
US7618649 Extended release oral dosage composition 19 Dec, 2020 Expired
US8187630 Extended release oral dosage composition 19 Dec, 2020 Expired
US7067502 Combinations of formoterol and mometasone furoate for asthma 21 Nov, 2020 Expired
US7566705 Combination of formoterol and mometasone furoate for asthma 21 Nov, 2020 Expired
US7067502 Combinations of formoterol and mometasone furoate for asthma 21 May, 2020 Expired
US7566705 Combination of formoterol and mometasone furoate for asthma 08 May, 2020 Expired
US6100274 8-chloro-6,11-dihydro-11- ](4-piperidylidine)-5H-benzo[5,6]cyclohepta[1,2-bpyridine oral compositions 07 Jan, 2020 Expired
US6100274 8-chloro-6,11-dihydro-11- ](4-piperidylidine)-5H-benzo[5,6]cyclohepta[1,2-bpyridine oral compositions 07 Jul, 2019 Expired
US5994329 Method for inhibiting bone resorption 17 Jan, 2019 Expired
US6503537 Preparation of powder agglomerates 17 Sep, 2018 Expired
US8173172 Preparation of powder agglomerates 17 Sep, 2018 Expired
US5994329 Method for inhibiting bone resorption 17 Jul, 2018 Expired
US6127353 Mometasone furoate monohydrate, process for making same and pharmaceutical compositions 03 Apr, 2018 Expired
US6503537 Preparation of powder agglomerates 17 Mar, 2018 Expired
US8173172 Preparation of powder agglomerates 17 Mar, 2018 Expired
US6127353 Mometasone furoate monohydrate, process for making same and pharmaceutical compositions 03 Oct, 2017 Expired
US6068832 Chlorofluorocarbon-free mometasone furoate aerosol formulations 27 Aug, 2017 Expired
US6240918 Powdered medication inhaler 20 Aug, 2017 Expired
US6240918 Powdered medication inhaler 20 Feb, 2017 Expired
US5829434 Inhaler for powdered medications 03 May, 2016 Expired
US5829434 Inhaler for powdered medications 03 Nov, 2015 Expired
US7214683 Compositions of descarboethoxyloratadine 30 Jun, 2015 Expired
US7214684 Methods for the treatment of allergic rhinitis 30 Jun, 2015 Expired
US5687710 Inhaler for powdered medications having spiral deagglomeration chamber 18 May, 2015 Expired
US7214683 Compositions of descarboethoxyloratadine 30 Dec, 2014 Expired
US7214684 Methods for the treatment of allergic rhinitis 30 Dec, 2014 Expired
US5687710 Inhaler for powdered medications having spiral deagglomeration chamber 18 Nov, 2014 Expired
US5889015 Use of mometasone furoate for treating lower airway passage and lung diseases 27 Jul, 2014 Expired
US6057307 Use of mometasone furoate for treating airway passage and lung diseases 27 Jul, 2014 Expired
US6365581 Use of mometasone furoate for treating airway passage and lung diseases 27 Jul, 2014 Expired
US6677322 Use of mometasone furoate for treating airway passage and lung diseases 27 Jul, 2014 Expired
US6949532 Use of mometasone furoate for treating airway passage and lung diseases 27 Jul, 2014 Expired
US5837699 Use of mometasone furoate for treating upper airway passage diseases 27 Jul, 2014 Expired
US6723713 Use of mometasone furoate for treating upper airway diseases 27 Jul, 2014 Expired
US5889015 Use of mometasone furoate for treating lower airway passage and lung diseases 27 Jan, 2014 Expired
US6057307 Use of mometasone furoate for treating airway passage and lung diseases 27 Jan, 2014 Expired
US6365581 Use of mometasone furoate for treating airway passage and lung diseases 27 Jan, 2014 Expired
US6677322 Use of mometasone furoate for treating airway passage and lung diseases 27 Jan, 2014 Expired
US6949532 Use of mometasone furoate for treating airway passage and lung diseases 27 Jan, 2014 Expired
US6677323 Use of mometasone furoate for treating airway passage and lung diseases 27 Jan, 2014 Expired
US5837699 Use of mometasone furoate for treating upper airway passage diseases 27 Jan, 2014 Expired
US6723713 Use of mometasone furoate for treating upper airway diseases 27 Jan, 2014 Expired
US5358941 Dry mix formulation for bisphosphonic acids with lactose 02 Jun, 2013 Expired
US5681590 Dry mix formulation for bisphosphonic acids 02 Jun, 2013 Expired
US6090410 Dry mix formulation for bisphosphonic acids 02 Jun, 2013 Expired
US5298520 Triazole containing indole derivatives 29 Dec, 2012 Expired
US5394868 Inhalation device for powdered medicaments 25 Dec, 2012 Expired
US5358941 Dry mix formulation for bisphosphonic acids with lactose 02 Dec, 2012 Expired
US5681590 Dry mix formulation for bisphosphonic acids 02 Dec, 2012 Expired
US6090410 Dry mix formulation for bisphosphonic acids 02 Dec, 2012 Expired
US5602162 Imidazole, triazole and tetrazole derivatives 28 Jul, 2012 Expired


Given below is the list of recent legal activities going on the following drug patents of Organon Llc.

Activity Date Patent Number
Patent litigations
Expire Patent 01 Jul, 2024 US8187630
Maintenance Fee Reminder Mailed 15 Jan, 2024 US8187630
Change in Power of Attorney (May Include Associate POA) 29 Dec, 2021 US11129896
Email Notification 29 Dec, 2021 US11129896
Correspondence Address Change 27 Dec, 2021 US11129896
Expire Patent 20 Dec, 2021 US7618649
Recordation of Patent Grant Mailed 28 Sep, 2021 US11129896
Patent Issue Date Used in PTA Calculation 28 Sep, 2021 US11129896
Email Notification 09 Sep, 2021 US11129896
Issue Notification Mailed 08 Sep, 2021 US11129896
Expire Patent 30 Aug, 2021 US7566705
Application Is Considered Ready for Issue 25 Aug, 2021 US11129896
Dispatch to FDC 25 Aug, 2021 US11129896
Issue Fee Payment Verified 23 Aug, 2021 US11129896
Issue Fee Payment Received 23 Aug, 2021 US11129896


Organon Llc's Drug Patent Litigations

Organon Llc's drugs have been subject to various legal proceedings, including patent litigations. The earliest legal proceeding was initiated on Dec 09, 2004, against patent number US7214683. The petitioner , challenged the validity of this patent, with ABERG et al as the respondent. Click below to track the latest information on how companies are challenging Organon Llc's patents.

Patent Proceeding Filing Date Status Respondent Petitioner
Patent litigations
US7214683 December, 2004 Decision
(24 Mar, 2005)
ABERG et al


Organon Llc's Family Patents

Organon Llc drugs have patent protection in a total of 10 countries. It's US patent count contributes only to 35.7% of its total global patent coverage. Click below to unlock the full patent family tree.

Family Patents



Organon Llc Drug List

Given below is the complete list of Organon Llc's drugs and the patents protecting them.


1. Asmanex Hfa

Asmanex Hfa is protected by 7 patents, out of which all have expired. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US6068832 Chlorofluorocarbon-free mometasone furoate aerosol formulations 27 Aug, 2017
(7 years ago)
Expired
US5889015
(Pediatric)
Use of mometasone furoate for treating lower airway passage and lung diseases 27 Jul, 2014
(10 years ago)
Expired
US6057307
(Pediatric)
Use of mometasone furoate for treating airway passage and lung diseases 27 Jul, 2014
(10 years ago)
Expired
US6365581
(Pediatric)
Use of mometasone furoate for treating airway passage and lung diseases 27 Jul, 2014
(10 years ago)
Expired
US5889015 Use of mometasone furoate for treating lower airway passage and lung diseases 27 Jan, 2014
(10 years ago)
Expired
US6057307 Use of mometasone furoate for treating airway passage and lung diseases 27 Jan, 2014
(10 years ago)
Expired
US6365581 Use of mometasone furoate for treating airway passage and lung diseases 27 Jan, 2014
(10 years ago)
Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Asmanex Hfa's drug page


2. Asmanex Twisthaler

Asmanex Twisthaler is protected by 21 patents, out of which all have expired. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US6503537
(Pediatric)
Preparation of powder agglomerates 17 Sep, 2018
(6 years ago)
Expired
US8173172
(Pediatric)
Preparation of powder agglomerates 17 Sep, 2018
(6 years ago)
Expired
US6503537 Preparation of powder agglomerates 17 Mar, 2018
(6 years ago)
Expired
US8173172 Preparation of powder agglomerates 17 Mar, 2018
(6 years ago)
Expired
US6240918
(Pediatric)
Powdered medication inhaler 20 Aug, 2017
(7 years ago)
Expired
US6240918 Powdered medication inhaler 20 Feb, 2017
(7 years ago)
Expired
US5829434
(Pediatric)
Inhaler for powdered medications 03 May, 2016
(8 years ago)
Expired
US5829434 Inhaler for powdered medications 03 Nov, 2015
(9 years ago)
Expired
US5687710
(Pediatric)
Inhaler for powdered medications having spiral deagglomeration chamber 18 May, 2015
(9 years ago)
Expired
US5687710 Inhaler for powdered medications having spiral deagglomeration chamber 18 Nov, 2014
(10 years ago)
Expired
US5889015
(Pediatric)
Use of mometasone furoate for treating lower airway passage and lung diseases 27 Jul, 2014
(10 years ago)
Expired
US6057307
(Pediatric)
Use of mometasone furoate for treating airway passage and lung diseases 27 Jul, 2014
(10 years ago)
Expired
US6365581
(Pediatric)
Use of mometasone furoate for treating airway passage and lung diseases 27 Jul, 2014
(10 years ago)
Expired
US6677322
(Pediatric)
Use of mometasone furoate for treating airway passage and lung diseases 27 Jul, 2014
(10 years ago)
Expired
US6949532
(Pediatric)
Use of mometasone furoate for treating airway passage and lung diseases 27 Jul, 2014
(10 years ago)
Expired
US5889015 Use of mometasone furoate for treating lower airway passage and lung diseases 27 Jan, 2014
(10 years ago)
Expired
US6057307 Use of mometasone furoate for treating airway passage and lung diseases 27 Jan, 2014
(10 years ago)
Expired
US6365581 Use of mometasone furoate for treating airway passage and lung diseases 27 Jan, 2014
(10 years ago)
Expired
US6677322 Use of mometasone furoate for treating airway passage and lung diseases 27 Jan, 2014
(10 years ago)
Expired
US6949532 Use of mometasone furoate for treating airway passage and lung diseases 27 Jan, 2014
(10 years ago)
Expired
US5394868
(Pediatric)
Inhalation device for powdered medicaments 25 Dec, 2012
(11 years ago)
Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Asmanex Twisthaler's drug page


3. Clarinex-d 12 Hour

Clarinex-d 12 Hour is protected by 10 patents, out of which all have expired. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US7618649
(Pediatric)
Extended release oral dosage composition 19 Jun, 2021
(3 years ago)
Expired
US6709676 Extended release oral dosage composition 18 Feb, 2021
(3 years ago)
Expired
US7618649 Extended release oral dosage composition 19 Dec, 2020
(3 years ago)
Expired
US8187630 Extended release oral dosage composition 19 Dec, 2020
(3 years ago)
Expired
US6100274
(Pediatric)
8-chloro-6,11-dihydro-11- ](4-piperidylidine)-5H-benzo[5,6]cyclohepta[1,2-bpyridine oral compositions 07 Jan, 2020
(4 years ago)
Expired
US6100274 8-chloro-6,11-dihydro-11- ](4-piperidylidine)-5H-benzo[5,6]cyclohepta[1,2-bpyridine oral compositions 07 Jul, 2019
(5 years ago)
Expired
US7214683
(Pediatric)
Compositions of descarboethoxyloratadine 30 Jun, 2015
(9 years ago)
Expired
US7214684
(Pediatric)
Methods for the treatment of allergic rhinitis 30 Jun, 2015
(9 years ago)
Expired
US7214683 Compositions of descarboethoxyloratadine 30 Dec, 2014
(9 years ago)
Expired
US7214684 Methods for the treatment of allergic rhinitis 30 Dec, 2014
(9 years ago)
Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Clarinex-d 12 Hour's drug page


4. Dulera

Dulera is protected by 10 patents, out of which all have expired. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US7067502
(Pediatric)
Combinations of formoterol and mometasone furoate for asthma 21 Nov, 2020
(4 years ago)
Expired
US7566705
(Pediatric)
Combination of formoterol and mometasone furoate for asthma 21 Nov, 2020
(4 years ago)
Expired
US7067502 Combinations of formoterol and mometasone furoate for asthma 21 May, 2020
(4 years ago)
Expired
US7566705 Combination of formoterol and mometasone furoate for asthma 08 May, 2020
(4 years ago)
Expired
US6068832 Chlorofluorocarbon-free mometasone furoate aerosol formulations 27 Aug, 2017
(7 years ago)
Expired
US5889015
(Pediatric)
Use of mometasone furoate for treating lower airway passage and lung diseases 27 Jul, 2014
(10 years ago)
Expired
US6057307
(Pediatric)
Use of mometasone furoate for treating airway passage and lung diseases 27 Jul, 2014
(10 years ago)
Expired
US5889015 Use of mometasone furoate for treating lower airway passage and lung diseases 27 Jan, 2014
(10 years ago)
Expired
US6057307 Use of mometasone furoate for treating airway passage and lung diseases 27 Jan, 2014
(10 years ago)
Expired
US6677323 Use of mometasone furoate for treating airway passage and lung diseases 27 Jan, 2014
(10 years ago)
Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Dulera's drug page


5. Fosamax Plus D

Fosamax Plus D is protected by 8 patents, out of which all have expired. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US5994329
(Pediatric)
Method for inhibiting bone resorption 17 Jan, 2019
(5 years ago)
Expired
US5994329 Method for inhibiting bone resorption 17 Jul, 2018
(6 years ago)
Expired
US5358941
(Pediatric)
Dry mix formulation for bisphosphonic acids with lactose 02 Jun, 2013
(11 years ago)
Expired
US5681590
(Pediatric)
Dry mix formulation for bisphosphonic acids 02 Jun, 2013
(11 years ago)
Expired
US6090410
(Pediatric)
Dry mix formulation for bisphosphonic acids 02 Jun, 2013
(11 years ago)
Expired
US5358941 Dry mix formulation for bisphosphonic acids with lactose 02 Dec, 2012
(11 years ago)
Expired
US5681590 Dry mix formulation for bisphosphonic acids 02 Dec, 2012
(11 years ago)
Expired
US6090410 Dry mix formulation for bisphosphonic acids 02 Dec, 2012
(11 years ago)
Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Fosamax Plus D's drug page


Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

6. Maxalt

Maxalt is protected by 2 patents, out of which all have expired. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US5298520
(Pediatric)
Triazole containing indole derivatives 29 Dec, 2012
(11 years ago)
Expired
US5602162
(Pediatric)
Imidazole, triazole and tetrazole derivatives 28 Jul, 2012
(12 years ago)
Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Maxalt's drug page


7. Nasonex

Nasonex is protected by 6 patents, out of which all have expired. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US6127353
(Pediatric)
Mometasone furoate monohydrate, process for making same and pharmaceutical compositions 03 Apr, 2018
(6 years ago)
Expired
US6127353 Mometasone furoate monohydrate, process for making same and pharmaceutical compositions 03 Oct, 2017
(7 years ago)
Expired
US5837699
(Pediatric)
Use of mometasone furoate for treating upper airway passage diseases 27 Jul, 2014
(10 years ago)
Expired
US6723713
(Pediatric)
Use of mometasone furoate for treating upper airway diseases 27 Jul, 2014
(10 years ago)
Expired
US5837699 Use of mometasone furoate for treating upper airway passage diseases 27 Jan, 2014
(10 years ago)
Expired
US6723713 Use of mometasone furoate for treating upper airway diseases 27 Jan, 2014
(10 years ago)
Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Nasonex's drug page


8. Xaciato

Xaciato is protected by 1 patent, which is still active. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US11129896 Topical formulations and treatments 22 Sep, 2036
(11 years from now)
Active

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Xaciato's drug page


Organon Llc News

Reuters reports that there may be a potential connection between mental health issues and the previous popular asthma drug, Singulair, developed by Merck.

22 Nov, 2024

Organon expands its presence in the dermatology sector through the acquisition of Roivant's dermatology subsidiary

18 Sep, 2024

Organon to acquire Dermavant and its steroid-free skin cream Vtama for a sum up to $1.2B

18 Sep, 2024

See More